Accumulation and elimination of a novel metabolite during chronic administration of the phenothiazine drug perazine to rats.
D000818:Animals; D001921:Brain / Q000378:metabolism; D002855:Chromatography, Thin Layer; D005029:Ethylenediamines / Q000096:biosynthesis; D007668:Kidney / Q000378:metabolism; D007700:Kinetics; D008099:Liver / Q000166:cytology / Q000378:metabolism; D008168:Lung / Q000378:metabolism; D008297:Male; D051379:Mice; D008862:Microsomes, Liver / Q000378:metabolism; D008930:Mitochondria, Liver / Q000378:metabolism; D010640:Phenothiazines / Q000096:biosynthesis / Q000378:metabolism*; D010879:Piperazines / Q000096:biosynthesis; D011437:Propylamines / Q000096:biosynthesis; D011817:Rabbits; D051381:Rats; D011919:Rats, Inbred Strains; D013053:Spectrophotometry; D013154:Spleen / Q000378:metabolism; D013347:Subcellular Fractions / Q000378:metabolism; D014149:Tranquilizing Agents / Q000378:metabolism*; D014466:Ultraviolet Rays
D005029:Ethylenediamines; D010640:Phenothiazines; D010879:Piperazines; D011437:Propylamines; D014149:Tranquilizing Agents